FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1515678748> ?p ?o ?g. }

• W1515678748 endingPage "1447" @default.
• W1515678748 startingPage "1437" @default.
• W1515678748 abstract "Dopamine D3 receptors have been pharmacologically engaged in humans since the development of the first antipsychotics and ergot-derivative dopamine (DA) agonists, even without knowing it. These agents were generally non-selective, developed primarily to target D2 receptors. In the last 10 years the understanding of the clinical implication of D3 receptors has been progressing also due to the identification of D3 gene polymorphisms, the use of more selective PET ligands such as [(11)C]-(+)-PHNO and the learning regarding the clinical use of the D3-preferential D2/D3 agonists ropinirole and pramipexole. A new specific neuroplasticity role of D3 receptor regarding dendrite arborisation outgrowth in dopaminergic neurons was also proposed to support, at least in part, the slowing of disease observed in subjects with Parkinson׳s Disease treated with DA agonists. Similar mechanisms could be at the basis of the antidepressant-like effects observed with DA agonists when co-administered with standard of care. Severe adverse event occurring with the use of anti-parkinsonian DA agonists in predisposed subjects, i.e., impulse control disorders, are now suggested to be putatively related to overactive D3 receptors. Not surprisingly, blockade of D3 receptors was proposed as treatment for addictive disorders, a goal that could be potentially achieved by repositioning buspirone, an anxiolytic drug with D3-preferential antagonistic features, or with novel selective D3 antagonists or partial agonists currently in development for schizophrenia. At the moment ABT-925 is the only selective D3 antagonist tested in schizophrenic patients in Phase II, showing an intriguing cognitive enhancing effects supported by preclinical data. Finally, exploratory pharmacogenetic analysis suggested that ABT-925 could be effective in a subpopulation of patients with a polymorphism on the D3 receptor, opening to a possible personalised medicine approach." @default.
• W1515678748 created "2016-06-24" @default.
• W1515678748 creator A5030315869 @default.
• W1515678748 creator A5033548247 @default.
• W1515678748 date "2015-09-01" @default.
• W1515678748 modified "2023-10-16" @default.
• W1515678748 title "Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs" @default.
• W1515678748 cites W1933744399 @default.
• W1515678748 cites W1965745229 @default.
• W1515678748 cites W1966092598 @default.
• W1515678748 cites W1967620263 @default.
• W1515678748 cites W1967823110 @default.
• W1515678748 cites W1968532777 @default.
• W1515678748 cites W1970668683 @default.
• W1515678748 cites W1972012028 @default.
• W1515678748 cites W1997887984 @default.
• W1515678748 cites W1999673371 @default.
• W1515678748 cites W1999982639 @default.
• W1515678748 cites W2003517512 @default.
• W1515678748 cites W2006437442 @default.
• W1515678748 cites W2006581907 @default.
• W1515678748 cites W2008734450 @default.
• W1515678748 cites W2011297026 @default.
• W1515678748 cites W2012210667 @default.
• W1515678748 cites W2017260929 @default.
• W1515678748 cites W2017307344 @default.
• W1515678748 cites W2021636487 @default.
• W1515678748 cites W2021784043 @default.
• W1515678748 cites W2027886428 @default.
• W1515678748 cites W2028332852 @default.
• W1515678748 cites W2028689689 @default.
• W1515678748 cites W2029996644 @default.
• W1515678748 cites W2038911569 @default.
• W1515678748 cites W2040439798 @default.
• W1515678748 cites W2044372141 @default.
• W1515678748 cites W2047659940 @default.
• W1515678748 cites W2061708711 @default.
• W1515678748 cites W2068022034 @default.
• W1515678748 cites W2071952162 @default.
• W1515678748 cites W2080386276 @default.
• W1515678748 cites W2086627093 @default.
• W1515678748 cites W2087557453 @default.
• W1515678748 cites W2090518397 @default.
• W1515678748 cites W2090592015 @default.
• W1515678748 cites W2092778523 @default.
• W1515678748 cites W2093875556 @default.
• W1515678748 cites W2093974148 @default.
• W1515678748 cites W2096067506 @default.
• W1515678748 cites W2096643782 @default.
• W1515678748 cites W2106027823 @default.
• W1515678748 cites W2106350754 @default.
• W1515678748 cites W2106966901 @default.
• W1515678748 cites W2110971533 @default.
• W1515678748 cites W2117405208 @default.
• W1515678748 cites W2126197018 @default.
• W1515678748 cites W2127272758 @default.
• W1515678748 cites W2133303620 @default.
• W1515678748 cites W2133960751 @default.
• W1515678748 cites W2137324630 @default.
• W1515678748 cites W2138684224 @default.
• W1515678748 cites W2140072622 @default.
• W1515678748 cites W2142013939 @default.
• W1515678748 cites W2142544704 @default.
• W1515678748 cites W2152837663 @default.
• W1515678748 cites W2153640583 @default.
• W1515678748 cites W2154314603 @default.
• W1515678748 cites W2154711995 @default.
• W1515678748 cites W2162345704 @default.
• W1515678748 cites W2166060597 @default.
• W1515678748 cites W2167223183 @default.
• W1515678748 cites W2168954492 @default.
• W1515678748 cites W2169584475 @default.
• W1515678748 cites W2319900294 @default.
• W1515678748 cites W270675275 @default.
• W1515678748 cites W4231861320 @default.
• W1515678748 cites W45776812 @default.
• W1515678748 doi "https://doi.org/10.1016/j.euroneuro.2015.07.012" @default.
• W1515678748 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26298833" @default.
• W1515678748 hasPublicationYear "2015" @default.
• W1515678748 type Work @default.
• W1515678748 sameAs 1515678748 @default.
• W1515678748 citedByCount "35" @default.
• W1515678748 countsByYear W15156787482015 @default.
• W1515678748 countsByYear W15156787482016 @default.
• W1515678748 countsByYear W15156787482017 @default.
• W1515678748 countsByYear W15156787482018 @default.
• W1515678748 countsByYear W15156787482019 @default.
• W1515678748 countsByYear W15156787482020 @default.
• W1515678748 countsByYear W15156787482021 @default.
• W1515678748 countsByYear W15156787482022 @default.
• W1515678748 countsByYear W15156787482023 @default.
• W1515678748 crossrefType "journal-article" @default.
• W1515678748 hasAuthorship W1515678748A5030315869 @default.
• W1515678748 hasAuthorship W1515678748A5033548247 @default.
• W1515678748 hasConcept C120069818 @default.
• W1515678748 hasConcept C126322002 @default.
• W1515678748 hasConcept C137183658 @default.
• W1515678748 hasConcept C15744967 @default.

• next